EASD 2016: Semaglutide Steals The Show With Impressive Cardiovascular Outcomes Data

 
• By Aine Slowey
  
Pipeline
Good news for Novo's diabetes pipeline
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category